Boost Your Xarelto Lawsuit With These Tips

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, which includes the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use - and failure to do so may be grounds for compensation. Our lawyers are operating difficult to acquire these hurt by the drug the compensation they are entitled to.

Even though bleeding is actually a common complication linked with anticoagulants, it has been alleged that Xarelto is much more unsafe than standard blood thinners because no antidote exists to reverse its blood-thinning effects. This signifies that, in the event of an emergency, individuals may possibly be at risk for irreversible bleeding issues, like life-threatening internal and gastrointestinal hemorrhaging.

In the event you or perhaps a loved one suffered a serious bleeding event after taking Xarelto, you might have legal recourse. For more info, make contact with us these days to possess your case reviewed, totally free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in situations of death, funeral expenses. Furthermore, they are looking for punitive damages, which are usually awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs inside her explanation the lawsuits allege severe and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for much more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.